BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 11553848)

  • 1. Molecular and transcriptional regulation of megakaryocyte differentiation.
    Shivdasani RA
    Stem Cells; 2001; 19(5):397-407. PubMed ID: 11553848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular biology of megakaryocyte differentiation in the absence of lineage-restricted transcription factors.
    Lecine P; Shivdasani RA
    Stem Cells; 1998; 16 Suppl 2():91-5. PubMed ID: 11012181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of transcription factor NF-E2 in megakaryocyte maturation and platelet production.
    Shivdasani RA
    Stem Cells; 1996; 14 Suppl 1():112-5. PubMed ID: 11012210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines.
    Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S
    Stem Cells; 2001; 19(4):339-47. PubMed ID: 11463954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development.
    Shivdasani RA; Fujiwara Y; McDevitt MA; Orkin SH
    EMBO J; 1997 Jul; 16(13):3965-73. PubMed ID: 9233806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of gene transcription during the differentiation of megakaryocytes.
    Uzan G; Prandini MH; Berthier R
    Thromb Haemost; 1995 Jul; 74(1):210-2. PubMed ID: 8578459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo.
    Fock EL; Yan F; Pan S; Chong BH
    Exp Hematol; 2008 Jan; 36(1):78-92. PubMed ID: 17923245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype.
    Kacena MA; Gundberg CM; Nelson T; Horowitz MC
    Bone; 2005 Feb; 36(2):215-23. PubMed ID: 15780947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D3 and megakaryocyte development: exploration of a transgenic phenotype.
    Zimmet JM; Toselli P; Ravid K
    Stem Cells; 1998; 16 Suppl 2():97-106. PubMed ID: 11012182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol.
    Nagata Y; Yoshikawa J; Hashimoto A; Yamamoto M; Payne AH; Todokoro K
    Genes Dev; 2003 Dec; 17(23):2864-9. PubMed ID: 14665668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiation.
    Vitrat N; Letestu R; Massé A; Lazar V; Vainchenker W; Debili N
    Thromb Haemost; 2000 May; 83(5):759-68. PubMed ID: 10823275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor GATA-1 in megakaryocyte development.
    Orkin SH; Shivdasani RA; Fujiwara Y; McDevitt MA
    Stem Cells; 1998; 16 Suppl 2():79-83. PubMed ID: 11012179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoiesis: new concepts.
    van Geet C
    Verh K Acad Geneeskd Belg; 2004; 66(1):5-24; discussion 24-7. PubMed ID: 15074080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokines and transcription factors in megakaryocytopoiesis.
    Yang M; Li K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):580-5. PubMed ID: 12513728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.
    Shivdasani RA; Rosenblatt MF; Zucker-Franklin D; Jackson CW; Hunt P; Saris CJ; Orkin SH
    Cell; 1995 Jun; 81(5):695-704. PubMed ID: 7774011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells.
    Chuen CK; Li K; Yang M; Fok TF; Li CK; Chui CM; Yuen PM
    J Lab Clin Med; 2004 Feb; 143(2):75-88. PubMed ID: 14966463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
    Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
    Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes.
    Lecine P; Villeval JL; Vyas P; Swencki B; Xu Y; Shivdasani RA
    Blood; 1998 Sep; 92(5):1608-16. PubMed ID: 9716588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of GATA-1 deficiency in megakaryocytes and platelets.
    Vyas P; Ault K; Jackson CW; Orkin SH; Shivdasani RA
    Blood; 1999 May; 93(9):2867-75. PubMed ID: 10216081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for Rab27b in NF-E2-dependent pathways of platelet formation.
    Tiwari S; Italiano JE; Barral DC; Mules EH; Novak EK; Swank RT; Seabra MC; Shivdasani RA
    Blood; 2003 Dec; 102(12):3970-9. PubMed ID: 12907454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.